Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$90.3M Buy
703,007
+27,039
+4% +$3.16M 0.49% 34
2026
Q1
$81.3M Buy
675,968
+21,496
+3% +$2.48M 0.53% 30
2025
Q4
$68.9M Buy
654,472
+20,087
+3% +$1.89M 0.45% 37
2025
Q3
$53.2M Buy
634,385
+20,600
+3% +$1.7M 0.37% 42
2025
Q2
$48.6M Buy
613,785
+32,767
+6% +$2.6M 0.38% 44
2025
Q1
$52.2M Buy
581,018
+32,543
+6% +$3.04M 0.48% 33
2024
Q4
$54.6M Buy
548,475
+32,108
+6% +$3.31M 0.51% 27
2024
Q3
$58.6M Buy
516,367
+33,717
+7% +$4.01M 0.59% 24
2024
Q2
$59.8M Buy
482,650
+36,768
+8% +$4.74M 0.68% 21
2024
Q1
$58.8M Buy
445,882
+1,989
+0.4% +$245K 0.76% 20
2023
Q4
$48.4M Buy
443,893
+387
+0.1% +$40.2K 0.69% 21
2023
Q3
$45.7M Buy
443,506
+143,207
+48% +$15.4M 0.73% 22
2023
Q2
$34.7M Buy
300,299
+1,616
+0.5% +$183K 0.79% 20
2023
Q1
$31.8M Buy
298,683
+1,793
+0.6% +$194K 0.79% 21
2022
Q4
$32.9M Buy
296,890
+2,487
+0.8% +$254K 0.88% 21
2022
Q3
$25.4M Buy
+294,403
New +$26.3M 0.72% 23

Other funds holding MRK

Czech National Bank's MRK Position: Q2 2026 in Review

Czech National Bank increased its Merck (MRK) stake by 4% in Q2 2026, buying an estimated $3.16M and bringing the position to 703,007 shares worth $90.3M. The position accounts for 0.49% of the portfolio, ranked #34.

Czech National Bank first reported a position in MRK in Q3 2022 and has held it in 16 quarters since. 1,492 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Czech National Bank held 703,007 shares of Merck worth $90.3M as of Q2 2026.
  • Czech National Bank bought 27,039 Merck shares in Q2 2026, an estimated $3.16M.
  • Merck made up 0.49% of Czech National Bank's portfolio in Q2 2026, its #34 holding.
  • Czech National Bank first reported a position in Merck in Q3 2022 and has held it in 16 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.